| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/30/2002 | US20020064873 Stable neural stem cell lines |
| 05/30/2002 | US20020064869 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents |
| 05/30/2002 | US20020064865 Crystal protein for use in bological pest control |
| 05/30/2002 | US20020064859 Nuclelotide sequences coding heterologous protein for use in the treatment of cancer, infections, genetic and immunological disorder |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064851 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects |
| 05/30/2002 | US20020064850 Nucleotide sequences for use in generating fructose polymers for food processing |
| 05/30/2002 | US20020064846 Protein for use treatment of diabetes |
| 05/30/2002 | US20020064844 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064842 Renilla reniformis green fluorescent protein and mutants thereof |
| 05/30/2002 | US20020064828 Method of controlling the binding of calmyrin to presenilin |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064821 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 05/30/2002 | US20020064819 Polypeptide for use in the treatament and prevention of nervous system disorders |
| 05/30/2002 | US20020064818 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancer, nervous system, inflammatory and immunological disorders |
| 05/30/2002 | US20020064812 Plasmid for use in the treatment of blood disorders |
| 05/30/2002 | US20020064809 Cell separation method; detect preferential acoustic impedance at surface of fluid, determine physical properties of fluid, discharge fluid |
| 05/30/2002 | US20020064808 Focused acoustic energy for ejecting cells from a fluid |
| 05/30/2002 | US20020064807 Diagnosing prokaryotic infectiins; obtain sample with prokaryote present, inoculate substrate, culture, evalute culture prokaryote |
| 05/30/2002 | US20020064805 Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies |
| 05/30/2002 | US20020064803 Novel antibody compositions for preparing enriched eosinophil preparations |
| 05/30/2002 | US20020064802 Associating protein with chromosomes; monitor chromosome, detect target association position, transform cell, detect proteins association with chromosome |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064525 Anti-IgE vaccines |
| 05/30/2002 | US20020064521 Nucleic acids coding for both A and B chains of human p53, human leukocyte antigen(HLA) restricted murine T-cell receptor (TCR); transformed CD8+ cytotoxic T lymphocytes for immunotherapy of tumors that over-express p53 |
| 05/30/2002 | US20020064519 Administering non-autologous (allogeneic) mesenchymal stem cells (they are "invisible" to the immune system) to promote hematopoietic or progenitor cell engraftment; use as host cells in gene therapy or in tissue repair |
| 05/30/2002 | CA2439184A1 Aspergillus fumigatus cofilin |
| 05/30/2002 | CA2439164A1 Aspergillus fumigatus profilin |
| 05/30/2002 | CA2434760A1 Differentiated cells suitable for human therapy |
| 05/30/2002 | CA2429860A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/30/2002 | CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | CA2429699A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | CA2429666A1 Connective tissue substitutes, method of preparation and uses thereof |
| 05/30/2002 | CA2429576A1 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | CA2428979A1 Human erg2 potassium channel |
| 05/30/2002 | CA2426939A1 Cystoskeleton-associated proteins |
| 05/30/2002 | CA2421151A1 Modified vaccinia ankara virus variant |
| 05/30/2002 | CA2398924A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 05/30/2002 | CA2363951A1 Modulating ramp activity |
| 05/29/2002 | EP1209237A2 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 05/29/2002 | EP1209236A1 phosphomevalonate kinases from plants |
| 05/29/2002 | EP1209230A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 05/29/2002 | EP1209228A2 Environmental stress responsive promoter |
| 05/29/2002 | EP1209227A2 Cytochrome P450 hydroxylase, an important enzyme in brassinosteroid biosynthesis of plants |
| 05/29/2002 | EP1209226A2 Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70) |
| 05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
| 05/29/2002 | EP1208384A2 Methods and compositions for modulating oxidized ldl transport |
| 05/29/2002 | EP1208381A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208234A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 05/29/2002 | EP1208229A1 Methods and compositions for isolating high molecular weight dna from natural samples |
| 05/29/2002 | EP1208228A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 05/29/2002 | EP1208218A2 Methods and compositions for delivery of pharmaceutical agents |
| 05/29/2002 | EP1208216A2 Fatty acid desaturase gene from plants |
| 05/29/2002 | EP1208210A2 Archaeal replication accessory factors and methods of use |
| 05/29/2002 | EP1208208A2 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 05/29/2002 | EP1208203A2 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
| 05/29/2002 | EP1208202A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208200A2 Transgenic animal model for neurodegenerative diseases |
| 05/29/2002 | EP1208199A2 DNA CODING FOR $g(b)-TUBULIN AND USE THEREOF |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208197A1 Iren protein, its preparation and use |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208195A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208194A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 05/29/2002 | EP1208192A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208111A2 Genes encoding insect odorant receptors and uses thereof |
| 05/29/2002 | EP1207961A2 Methods of modification of selected cells in a magnetic cell separation column |
| 05/29/2002 | EP1207919A1 Humanized biomaterials, a process for their preparation and their applications |
| 05/29/2002 | EP1207876A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 05/29/2002 | EP1023599B1 A multicellular in vitro assay of angiogenesis |
| 05/29/2002 | EP0603190B1 Plant-derived enzyme and dna sequences, and uses thereof |
| 05/29/2002 | CN1351715A Use of genes of the deoxy-D-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
| 05/29/2002 | CN1351714A Tandem immuno-assay for cancer |
| 05/29/2002 | CN1351669A Chimeric promoters based on the plastocyanin PETE promoter from pea |
| 05/29/2002 | CN1351667A Transgenic plants that are resistant to a broad specrum of pathogens |
| 05/29/2002 | CN1351666A Recombinant bacterial phytases and uses thereof |
| 05/29/2002 | CN1351661A Compounds |
| 05/29/2002 | CN1351657A Polypeptides having alkaline 2-amylase activity and nucleic acids encoding same |
| 05/29/2002 | CN1351656A Human liver progenitors |
| 05/29/2002 | CN1351655A Method for cultivating cancer cells from human tissue and device for preparing tissue samples |
| 05/29/2002 | CN1351653A Anti-bacterial vaccine compositions |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351612A Novel organic anion transport proteins |
| 05/28/2002 | US6395963 Nematode-inducible regulatory DNA sequences |
| 05/28/2002 | US6395961 Gene transfer in chickens by introduction of DNA into muscle in ovo |
| 05/28/2002 | US6395960 A genetically engineered rodent; diagnosis and therapy for alzheimer's disease |
| 05/28/2002 | US6395959 Nucleotide sequence encoding the enzyme I SceI and the use thereof |
| 05/28/2002 | US6395958 Method of producing a polypeptide in an ungulate |
| 05/28/2002 | US6395884 Purifying human alpha galactosidase from human cells by passing cells over a hydrophobic interaction resin; therapy for fabry's disease |
| 05/28/2002 | US6395877 14273 receptor, a novel G-protein coupled receptor |
| 05/28/2002 | US6395715 Antitumor agents |
| 05/28/2002 | US6395714 Expressing gp140 fragment of primary HIV-1 isolate |
| 05/28/2002 | US6395712 Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |